Skip to main content

Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan

Takeda Pharmaceutical Co Ltd has asked regulators to approve the use of Moderna Inc’s COVID-19 vaccine (mRNA-1273 or TAK-919).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.